In the Name of empathy, patient satisfaction, and employee engagement, “PAYAM PET SCAN” was introduced in 2016 to continue building a strong base of engaged and committed caregivers who are dedicated to fulfilling PAYAM’s mission of putting patients first. PAYAM PET SCAN is the First private PET scan center equipped with PET-CT, PET-MAMMO, Cyclotron, and Conventional Nuclear Medicine, and the first phase of a CANCER CENTER OF EXCELLENCE.
Iran, Tehran
PET/CT represents a major paradigm shift in diagnosis: it takes us from conventional technologies that evaluate structural anatomy to a molecular modality that images the metabolic activity of the tissue.
Several imaging modalities have been introduced over recent years to better screen for and stage breast cancer. Positron emission mammography (PEM) has been approved by the US FDA and introduced into clinical use as a diagnostic adjunct to mammography and breast ultrasonography.
Conventional nuclear medicine imaging can be performed using various radiopharmaceuticals, mainly labeled with technetium-99m, and also uses gallium, thallium, and 131-I.
The various utilities of PET/CT in oncology can be categorized as follows:
After the histological diagnosis, to assess the extent of the disease before the start of treatment
Positron Emission tomography/ computerized tomography (PET/CT) is a technological advancement having a significant impact on oncology. 18Fluorine-2-fluoro-2-deoxy-D-glucose (18F-FDG) is an expensive, short-lived radiopharmaceutical used for PET/CT scanning and is synthesized in a cyclotron by a complex process. The net result is an expensive modality.
PAYAM PET SCAN CENTER has an advantage in that uses a dose of on-demand cyclotron which means we could do PET-CT 24 hours a day and 7 days of a week.